Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors

Published Date: 11 Sep 2024

A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrates a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.

Read Full News

Latest News

Best Treatments for BD: Current Evidence, New Online Tool

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool that helps clinicians and patients weigh efficacy, side effects, and individual preferences.

Add-On Citicoline May Improve Motor Function in PD

Citicoline added to dopaminergic therapy is safe and tied to higher odds of clinically meaningful improvement than placebo in motor function in Parkinson’s, a trial shows.

How Two Brains Can Quickly Be ‘On the Same Wavelength’

Researchers are learning which situations encourage neural synchrony — that increasingly elusive feeling of being ‘in flow’ with others — and how we can benefit.

Up the Ante for Lung Cancer Screening in Women

Rising incidence calls for more recognition of lung cancer risks in nonsmoking women.

As Federal Loan Cap Takes Effect, Medical Schools Step Up

Medical schools are reaching out to inform students and make more funds available after federal help shrinks. Students debate best options.

Brain Age Tied to Dementia Risk in Those With Memory Issues

An automated MRI measure shows that each extra year the brain appears older than chronologic age is linked to increased dementia risk, especially in patients with subjective cognitive concerns.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool that helps clinicians and patients weigh efficacy, side effects, and individual preferences.

Citicoline added to dopaminergic therapy is safe and tied to higher odds of clinically meaningful improvement than placebo in motor function in Parkinson’s, a trial shows.

Researchers are learning which situations encourage neural synchrony — that increasingly elusive feeling of being ‘in flow’ with others — and how we can benefit.

Rising incidence calls for more recognition of lung cancer risks in nonsmoking women.

Medical schools are reaching out to inform students and make more funds available after federal help shrinks. Students debate best options.

An automated MRI measure shows that each extra year the brain appears older than chronologic age is linked to increased dementia risk, especially in patients with subjective cognitive concerns.

News All Time

THC Safe, Effective for PTSD-Related Nightmares

Dronabinol, a medication containing THC, is linked to fewer nightmares at lower intensity compared to placebo in patients with post-traumatic stress disorder, new data show.

French Hospital Brings Phage Therapy Closer to Clinical Use

A first-in-world public authorization to manufacture GMP therapeutic phages could expand clinical trials, strengthen regulated access, and accelerate evidence-based treatment.

Self-Sampling Can Be Feasible for Respiratory Infections

A Swiss pilot study shows that self-sampling at home is feasible for detecting respiratory infections and supports creating a decentralised household-based cohort for pandemic preparedness.

Bipolar Disorder Linked to Higher Mortality in Older Adults

Bipolar disorder is associated with a 72% increased risk for mortality over 8 years in older adults compared with the general population, a new prospective study shows.

Age and MRI Features Predict MS Odds After Initial Symptoms

Younger age at onset, multifocal symptoms, and specific MRI findings are associated with increased odds of multiple sclerosis diagnosis after a first demyelinating event.

Prostate Surgery Leakage Improves Over 12 Months

About 1 in 5 patients develop urinary incontinence 3 months after thulium fiber laser enucleation of the prostate, with rates decreasing over 12 months.

Nirsevimab Linked to Lower Risk for IPD Hospitalizations

Nirsevimab immunization in children younger than 12 months is linked to a lower risk for hospitalization for invasive pneumococcal disease, a French nationwide analysis shows.

‘Big Beautiful’ Law Tests Rural Hospital Lifeline

A century-old hospital near Michigan’s southern border was one of the nation’s first to convert into a new emergency-focused model Congress created to save rural care.

Romanian Healthcare Workers End Strike Over Pay, Staffing

Romanian healthcare workers ended a nationwide strike on ⁠Friday as the country's caretaker government approved new hires in ⁠short-staffed state hospitals.

Swimming Linked to Reduced Disability in Low Back Pain

Swimming plus education is more effective than education alone in reducing disability in adults with chronic low back pain over 8 weeks, a trial shows.

Preterm Lung Disease: One Drug Testing May Miss Responders

Most children born premature with chronic lung disease have reversible airway obstruction, but bronchodilator responses vary widely, underscoring the need for individualized testing.

Vancomycin Prophylaxis Tied to Lower C difficile Recurrence

In children and young adults with cancer, oral vancomycin prophylaxis during broad-spectrum antibiotic therapy is associated with a lower risk for recurrent Clostridioides difficile infection.

Spousal Dementia Tied to Higher Dementia Risk

Spouses of individuals with dementia have a significantly higher risk of developing dementia, new research shows.

Infections Tied to Increased Risk for Brain Disorders

Hospitalization due to an acute infection, especially infectious encephalitides, is linked to increased risk for psychiatric and neurologic disorders, a new study shows.

Romanian Healthcare Workers Strike Over Wage Bill Needed to Secure EU Funds

Thousands of Romanian doctors, nurses and other health workers went on an indefinite strike ⁠for the first time in a decade on Tuesday, protesting job freezes and a public...

The Restorative Power of ‘Sacred Moments’ in Medicine

Deep human connection can be a potent antidote to burnout. Here’s how to cultivate meaning in an increasingly rushed healthcare system.

Recommended News For You

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Sickle Cell Disease Drug Pulled From Global Markets

After two years, a significant left nasal obstruction was finally diagnosed.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

enhancing survivors of brain tumors' quality of life.

Recommended Articles For You

Strategic Standards in Hematology for Specialists 

Metabolic Vulnerabilities in Solid Tumor Progression 

Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology 

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: When will individuals be able to receive customized cancer vaccines?

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

4.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

5.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

1.

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer

2.

Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics

3.

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer 

4.

Personalized Tumor Ecological Landscapes in Oncology

5.

Unmasking the Subtle Symptoms of Colon Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Immunotherapy: A New Era in Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot